Akums Drugs and Pharmaceuticals Limited (NSE:AKUMS)
451.35
-12.65 (-2.73%)
At close: Feb 13, 2026
NSE:AKUMS Market Cap
NSE:AKUMS has a market cap or net worth of 69.1 billion as of February 13, 2026. Its market cap has decreased by -20.36% in one year.
Market Cap
69.10B
Enterprise Value
53.66B
Revenue
42.60B
Ranking
n/a
PE Ratio
21.72
Stock Price
451.35
Market Cap Chart
Since August 6, 2024, NSE:AKUMS's market cap has decreased from 125.32B to 69.10B, a decrease of -44.86%. That is a compound annual growth rate of -32.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 69.10B | -0.45% |
| Dec 31, 2025 | 69.42B | -30.92% |
| Dec 31, 2024 | 100.48B | -19.82% |
| Aug 6, 2024 | 125.32B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eris Lifesciences | 195.93B |
| Alembic Pharmaceuticals | 151.33B |
| NATCO Pharma | 147.56B |
| Cohance Lifesciences | 120.74B |
| Alivus Life Sciences | 112.89B |
| Strides Pharma Science | 79.05B |
| Aarti Pharmalabs | 64.29B |
| Sun Pharma Advanced Research Company | 42.87B |